- Increasing
value, visibility and transparency by becoming an OTCQB fully reporting
company
- High
Grade Full Spectrum Cannabinoids Line being expanded to 90,000 retail
outlets, with three additional chocolate products added to the line
- Distributing
vapes/e-liquids and gummy edibles in the recreational sector
- MSN-2
home medical testing kit allows for the testing of sexually transmitted
disease in the privacy of one’s own home
Earth Science Tech, Inc. (OTC: ETST), an innovative biotech
company focused on cannabis and cannabinoid research and development,
nutraceuticals, pharmaceuticals and medical devices, has initiated the
up-listing process in anticipation of its Form 10 Registration Statement being
approved. By becoming a fully reporting company listed on the OTCQB Venture
Market, the company expects to increase in value, visibility and
transparency (http://ibn.fm/ROn48).
By up-listing in anticipation of the approval, the company
is advancing its timeline to achieve fully reporting status. “Once ETST is an
OTCQB fully reporting company, we will attract many new investors while keeping
current shareholders pleased with our progress,” President, Director and
Chairman of ETST Nickolas S. Tabraue stated in a news release. “We can now
communicate with large-net-worth investors to acquire the needed funds to
strengthen our High-Grade Full Spectrum Cannabinoids line, KannaBidioiD line
and MSN-2 medical device and to exponentially increase our revenues overall.”
The up-listing holds promise of new potential investors and the company has a
number of exciting updates that it plans to share soon.
Investors can now help the company strengthen innovative,
and exciting updates already in the works.
- ETST’s
High Grade Full Spectrum Cannabinoids line is being introduced by AATAC,
an advisory board focused on convenience stores, to its 90,000 retail
outlets throughout the United States. In addition, three unique new
chocolate products are being formulated with joint venture partner
Karmavore Superfoods, bringing the company’s product line to five unique
CBD Raw Chocolate flavors. The launch of these new CBD-based formulas is
anticipated for the third quarter of 2018 (http://ibn.fm/wuhEW).
- KannaBidioiD,
Inc. is a wholly owned subsidiary of ETST that manufactures and
distributes vapes/e-liquids and gummy edibles in the recreational sector.
- ETST’s
Earth Science Pharmaceutical subsidiary develops medical diagnostic tools
which include the new MSN-2, a home medical testing kit. The kit is
designed for the detection of sexually transmitted infections (STI), and
the registration of the trademark is anticipated within the next nine to
10 months (http://ibn.fm/XWRUF).
Transparency is a key component in the expansion of ETST’s
business as it maintains the confidence of investors and works toward becoming
a fully reporting company listed on the OTCQB Venture Market.
For more information, visit the company’s website at www.EarthScienceTech.com
About MissionIR
MissionIR is
primarily focused on strategic communications. We have executed countless
communications programs to address the needs of companies ranging from
start-ups to established industry leaders, gaining valuable experience and the
expertise necessary to determine the most effective strategy for any given
situation.
For more information, visit www.MissionIR.com
MissionIR (MIR)
Please see full terms of use and disclaimers on the Mission
Investor Relations website applicable to all content provided by MIR, wherever
published or re-published: http://www.missionir.com/disclaimer.html
